Key Takeaways:
- Certis Biologicals has appointed Eda Reinot as its new President, with a future transition to CEO.
- Reinot brings extensive experience from her previous leadership roles at Indigo Ag, BASF, and Becker Underwood.
- Certis Biologicals, a subsidiary of Mitsui & Co., Ltd., offers a portfolio of over 40 bio-based products for pest, disease, and weed control.
- Reinot’s leadership aims to drive continued innovation in sustainable agriculture and enhance the company’s global market presence.
- The company recently introduced new products, including NemaClean® bionematicide and Convergence® biofungicide for large-acreage crops.
Certis Biologicals, a leader in bio-based agricultural innovations, has named Eda Reinot as its new President, with plans for her to transition to CEO. The company, a subsidiary of Mitsui & Co., Ltd., specializes in enhancing crop productivity and quality through bio-based solutions. Reinot’s appointment marks the beginning of a new chapter for the company, which has been at the forefront of biological crop protection technologies.
Eda Reinot’s Leadership Background
Reinot joins Certis Biologicals from her previous role as Vice President at Indigo Ag, where she led research and development (R&D), regulatory processes, bio-processing, and international product development. She also held senior positions at BASF and served as the Global Head of R&D at Becker Underwood, bringing decades of experience in driving innovation and product development in the agriculture sector.
Commenting on her new role, Reinot said, “The growth in the biological market has been unparalleled over the past decade. Throughout that trajectory, Certis Biologicals has consistently led based on its strength in and commitment to science-based innovation. That science-led approach is critical as we continue to bring to market products that help growers feed the world while enhancing the sustainability of their land, resources, and operations.”
Strategic Importance of Certis Biologicals
Certis Biologicals plays a key role in Mitsui & Co., Ltd.’s agricultural strategy. Hitoshi Kudo, General Manager of the AgriScience Division at Mitsui & Co., Ltd., expressed confidence in Reinot’s leadership. “We believe that Eda’s expertise and leadership will accelerate the growth and innovation of this business. Certis Biologicals is an integral part of our Ag strategy, which aims to create value for our customers, partners, and society.”
The company offers a diverse portfolio of bio-based products designed to control pests, diseases, and weeds across a variety of crops, including greenhouse, specialty, and large-acreage crops. Its product lineup includes Double Nickel®, Howler EVO®, and Theia®, among others. These products are globally distributed, with over 300 active ingredient and product registrations worldwide.
Certis Biologicals Recent News
Unveiling Convergence Biofungicide (2024/01/12)
In 2024, Certis Biologicals introduced Convergence™, a biofungicide aimed at helping row crop farmers enhance crop protection and health. This innovative product offers dual benefits: superior disease control against pathogens like Pythium, Rhizoctonia, and tar spot, and improved plant health, all while being cost-effective. Made from Bacillus amyloliquefaciens strain D747, it supports sustainable farming by protecting crops without harming beneficial insects. Convergence™ is designed for ease of use, allowing flexible application methods such as in-furrow or foliar treatments. Field trials, particularly in the Midwest, have shown notable yield increases in corn and soybeans. This launch aligns with Certis Biologicals’ mission to provide eco-friendly solutions for agriculture.
2 Comments